2 Monotherapy is no longer available in the USA since Jan 2023, and lixisenatide-glargine (iGlarLixi) has been approved for type 2 diabetes
Eren-Yazicioglu, C
Current guidelines recommend resistance training involving major muscle groups at least 2-3 days per week , with 1-3 sets of 8-15 repetitions per exercise
Orgain has introduced new GLP-1-compatible macronutrient shakes for DTC users
What to Expect From GLP-1 Medications The effects of GLP-1s can be felt almost immediately in some people
Overall, when administering GLP-1RA plus SGLT2i combination therapy, it is important to adopt an individualized approach to therapy taking into account individual preferences, costs and coverage, AE profile, consideration of kidney function and glucose-lowering efficacy, desire for weight loss, and comorbidities such as frailty [6, 22, 24]